About this trial

The purpose of this research is to explore the use of high-resolution microvessel ultrasound imaging system to look for scarring and to monitor wound healing and to see if treatment affects the amount of tiny vessels and circulation around the wound.

Eligibility criteria

Qualifiers

Chronic wound in the course of diabetic foot ulcers and/or lower extremity venous ulcers with duration of at least 6 weeks and the wound surface not less than 2 sq. cm and not greater than 15 sq. cm, without evidence of active infection of the wound at the time of qualification to participate in the study

Meets criteria for stalled chronic wound defined as less than 50% reduction in wound size after 30 days of standard of care management.

For chronic venous ulcers, ultrasound demonstrates venous reflux >0.5 seconds

Satisfactory blood glucose control - fasting not more than 110 mg%, HbA1c <6.5%

Disqualifiers

Acute wound with duration less than 6 weeks

Evidence of active infection or on antibiotics

Smoker

For chronic venous ulcers, ultrasound demonstrates venous reflux <0.5 seconds

Trial design

Treatments tested in this trial

  • Microvessel Ultrasound Examination
  • Skin Biopsy

Treatment groups

10 Participants
are divided into 1 treatment group

Locations

1
Mayo Clinic Minnesota55905, RochesterMinnesota, United States

Sponsors and collaborators

Mayo Clinic

Lead sponsor